{"DataElement":{"publicId":"2183421","version":"1","preferredName":"Patient Neoplasm Personal Medical History Ind-2","preferredDefinition":"the yes/no indicator related to a person who receives medical attention, care, or treatment with history of an abnormal tissue growth resulted from uncontrolled cell proliferation.","longName":"PRI_PT_TUMOR_HX_IND2","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2957976","version":"1","preferredName":"Patient Neoplasm Personal Medical History","preferredDefinition":"information related to a person who receives medical attention, care, or treatment with history of an abnormal tissue growth resulted from uncontrolled cell proliferation.","longName":"2233604v1.0:2957974v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2957974","version":"1","preferredName":"Neoplasm Personal Medical History","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:an account of all medical events and problems a person has experienced.","longName":"C3262:C18772","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Personal Medical History","conceptCode":"C18772","definition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7790ED63-7018-341E-E040-BB89AD435893","latestVersionIndicator":"Yes","beginDate":"2009-11-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-11-04","modifiedBy":"ONEDATA","dateModified":"2009-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7790ED63-7029-341E-E040-BB89AD435893","latestVersionIndicator":"Yes","beginDate":"2009-11-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-11-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000421","version":"1","longName":"GOG-0225","context":"NRG"},{"publicId":"10000422","version":"1","longName":"GOG-0225","context":"NRG"},{"publicId":"4104911","version":"1","longName":"GOG-0225","context":"NRG"},{"publicId":"4104895","version":"1","longName":"GOG-0238","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"4104994","version":"1","longName":"RTOG-1201","context":"NRG"},{"publicId":"4104884","version":"1","longName":"GOG-0244","context":"NRG"},{"publicId":"10000341","version":"1","longName":"GOG-0244","context":"NRG"},{"publicId":"10000340","version":"1","longName":"GOG-0244","context":"NRG"},{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"},{"publicId":"4104996","version":"1","longName":"GOG-0279","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4058120","version":"1","longName":"GOG-0278","context":"NRG"},{"publicId":"4104915","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"10000592","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"10000591","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"4104916","version":"1","longName":"GOG-0257","context":"NRG"},{"publicId":"10000500","version":"1","longName":"GOG-0257","context":"NRG"},{"publicId":"10000499","version":"1","longName":"GOG-0257","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"},{"publicId":"4104885","version":"1","longName":"GOG-0263","context":"NRG"},{"publicId":"4104995","version":"1","longName":"GOG-0269","context":"NRG"},{"publicId":"4104991","version":"1","longName":"GOG-0275","context":"NRG"}]}],"AlternateNames":[{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"PRI_PT_TUMOR_HX_IND2","type":"USED_BY","context":"NRG"},{"name":"PRI_PT_TUMOR_HX_IND2","type":"USED_BY","context":"CITN"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"PRI_PT_TUMOR_HX_IND2","type":"USED_BY","context":"CCTG"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"IE_IEORRES_PRMALIG","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Has the patient had any prior","type":"Preferred Question Text","description":"Has the patient had any prior malignancies in the past 5 years other than squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ of the colon or rectum, or carcinoma in situ of the cervix that has been effectively treated?","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Has the patient had a prior malignancy within the past 5 years","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"No prior invasive malignancies, unless disease-free for >= 5 years prior to pre-registration.","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"No prior malignancy within 5 years of registration (Exceptions: non-melanoma skin cancer, in-situ cancers)","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Does the patient have a history of the presence of other invasive malignancies, other than non-melanoma skin cancer, within the past 5 years?","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Does patient have history of any other malignancy, except adequately treated non melanoma skin cancer or curatively treated in situ carcinoma of the cervix or other solid tumors curatively treated with no evidence of disease for > 5 years?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"History of prior invasive malignancy","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Patient has a history of other malignancies except: adequately treated non-melanoma skin cancer or adequately treated superficial bladder cancer or other solid tumours curatively treated with no evidence of disease for >= 5 years from randomization","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Other active malignancy <=3 years prior to registration. EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix. NOTE: If there is a history of prior malignancy, they must not be receiving other specific treatment (other than hormonal therapy) for their cancer","url":null,"context":"CTEP"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Does the patient have any invasive malignancies (other than non-melanoma skin cancer) that have shown any evidence of the other cancer present within the last five years?","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Were the other malignancies limited to one or more of the following: in situ cancers treated only by local excision, and basal and squamous cell carcinomas of the skin?","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Other active malignancy <=3 years prior to randomization. EXCEPTIONS: Non-melanotic. Skin cancer or carcinoma-in-situ of the cervix. ","url":null,"context":"CTEP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Has the patient had other malignancies (other than carcinoma in situ of the cervix, colorectal carcinoma in situ, melanoma in situ, or basal cell or squamous cell carcinoma of the skin that has been treated)?","url":null,"context":"CTEP"},{"name":"CRF Text14","type":"Alternate Question Text","description":"Active other malignancy, excepting non-melanotic skin cancer or carcinoma-in-situ of the cervix.  If there is a history of prior malignancy, they must not be receiving other specific treatment (other than hormonal therapy) for their cancer","url":null,"context":"CTEP"},{"name":"CRF Text15","type":"Alternate Question Text","description":"Other active primary malignancy requiring treatment or limits survival to <24 months","url":null,"context":"CTEP"},{"name":"CRF Text18","type":"Alternate Question Text","description":"Does the patient have any other invasive malignancies, with the exception of non-melanoma skin cancer?","url":null,"context":"CTEP"},{"name":"CRF Text20","type":"Alternate Question Text","description":"Does the patient have a history of invasive malignancies, with the exception of non-melanoma skin cancer, and have evidence of other malignancy being present within the last five years?","url":null,"context":"CTEP"},{"name":"CRF Text19","type":"Alternate Question Text","description":"Does the patient have a history of other invasive malignancies if their previous cancer treatment included any of the surgical procedures described in section 3.11?","url":null,"context":"CTEP"},{"name":"CRF Text17","type":"Alternate Question Text","description":"History of other malignancy <=5 years with the exception of non-melanoma skin cancer or carcinoma in-situ of the cervix","url":null,"context":"CTEP"},{"name":"CRF Text16","type":"Alternate Question Text","description":"Other invasive malignancy <= 5 years prior to registration.  Exceptions are colonic polyps, non-melanoma skin cancer or carcinoma-in-situ of the cervix","url":null,"context":"CTEP"},{"name":"CRF Text22","type":"Alternate Question Text","description":"Were the other malignancies limited to one or more of the following: carcinoma in situ of the cervix, colorectal carcinoma in situ, melanoma in situ, and basal cell and squamous cell carcinoma of the skin?","url":null,"context":"CTEP"},{"name":"CRF Text24","type":"Alternate Question Text","description":"Does the patient have a history of other invasive malignancies, with the exception of non-melanoma skin cancer?","url":null,"context":"CTEP"},{"name":"CRF Text21","type":"Alternate Question Text","description":"Does the patient have a history of other invasive malignancy, if that malignancy included a bilateral lymph node procedure (ex. bilateral mastectomies and axillary lymphedenectomies)?","url":null,"context":"CTEP"},{"name":"CRF Text 26","type":"Alternate Question Text","description":"Does the patient have a history of  prior invasive malignancy(unless disease free for a minimum of 3 years ), excluding non-melanomatous skin cancer and previous early prostate cancer that had a non-rising PSA?","url":null,"context":"CTEP"},{"name":"CRF Text 27","type":"Alternate Question Text","description":"Concurrent or prior malignancy except for adequately treated basal or squamous cell skin cancer, adequately treated stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease-free for 5 years.","url":null,"context":"CTEP"},{"name":"CRF Text25","type":"Alternate Question Text","description":"Has the patient had any evidence of the presence of other invasive malignancies (with the exceptions of non-melanoma skin cancer, carcinoma in situ of the cervix and ductal carcinoma in situ of the breast) within the past 5 years?","url":null,"context":"CTEP"},{"name":"CRF Text30","type":"Alternate Question Text","description":"Does patient have a history of prior malignancy, with the exception of the following: a) Malignancy treated with curative intent and with no evidence of active disease present for more than 3 years prior to screening, and felt to be at low risk for recurrence by treating physician; b) Adequately treated non-melanomatous skin cancer or lentigo maligna melanoma without current evidence of disease; c) Adequately treated cervical carcinoma in situ without current evidence of disease","url":null,"context":"CTEP"},{"name":"CRF Text  31","type":"Alternate Question Text","description":"History of prior malignancy within the past 5 years other than surgically cured non-melanoma skin cancer or cervical carcinoma in-situ","url":null,"context":"CTEP"},{"name":"NRG_CRF Text","type":"Alternate Question Text","description":"Does the patient have a history of other invasive malignancies, with the exception of non-melanoma skin cancer, being present within the last five years?","url":null,"context":"NRG"},{"name":"GOG_CRF Text","type":"Alternate Question Text","description":"Does the patient have a history of other invasive malignancies, other than non-melanoma skin cancer or stage 1A endometrioid adenocarcinoma of the uterus, within the past 5 years?","url":null,"context":"NRG"},{"name":"CRF text 3","type":"Alternate Question Text","description":"Patient with prior malignancies other than ovarian cancer for which the patient has been disease free for 3 years, except treated and cured basal or squamous cell skin cancer, superficial bladder cancer, or carcinoma in situ of the cervix","url":null,"context":"CTEP"},{"name":"CRF Text 32","type":"Alternate Question Text","description":"If yes, is the second primary cancer adequately treated non-melanoma skin cancer, curatively treated in situ cancer of the cervix, Ductal Carcinoma in situ (DCIS) of the breast, stage 1 grade 1 endometrial carcinoma, or other solid tumours including lymphomas (without bone marrow involvement) curatively treated with no evidence of disease for >= 5 years prior to randomisation.  More than one course of chemotherapy for previous malignancies (e.g: breast cancer or ovarian cancer > 5 years ago treated with adjuvant chemotherapy)","url":null,"context":"CTEP"},{"name":"CRF Text 33","type":"Alternate Question Text","description":"Patients with prior malignancies, other than ovarian cancer, for which the patient has not been disease free for 3 years or more, except treated and cured basal or squamous cell skin cancer, superficial bladder cancer, or carcinoma in situ of the cervix.","url":null,"context":"CTEP"},{"name":"NRG_CRF text 2","type":"Alternate Question Text","description":"Does the patient have a history of prior invasive malignancies, with the exception of non-melanoma skin cancer and other specific malignancies as noted in section 3.3.5 being present in the last 3 years (2 years for breast cancer)?","url":null,"context":"NRG"},{"name":"CITN","type":"Alternate Question Text","description":"Non ductal adenocarcinomas, neuroendocrine neoplasms, cystic tumors of the pancreas such as cystadenomas, cystadenocarcinomas and solid pseudopapillary neoplasms. In addition, adenocarcinomas arising from duodenum, distal bile duct, and ampulla will also be excluded.","url":null,"context":"CITN"},{"name":"NRG_CRF text3","type":"Alternate Question Text","description":"Does the patient have a history of prior invasive malignancies, with the exception of non-melanoma skin cancer and other specific malignancies as noted in section 3.3.4 being present in the last 3 years (2 years for breast cancer)?","url":null,"context":"NRG"},{"name":"NRG_CRF text 4","type":"Alternate Question Text","description":"Does the patient have any concomitant or prior invasive malignancies?","url":null,"context":"NRG"},{"name":"CRF_Text_33","type":"Alternate Question Text","description":"Is the invasive malignancy one or more of the following: colonic polyps, non-melanoma skin cancer or carcinoma-in-situ of the cervix?","url":null,"context":"CTEP"},{"name":"CRF_Text_32","type":"Alternate Question Text","description":"Is it one of the following curatively treated: cervical carcinoma in situ, non-melanoma skin cancer, superficial bladder cancer (Ta [non-invasive tumor] and T1 [tumor invades lamina propria])?","url":null,"context":"CTEP"},{"name":"NRG_CRF Text6","type":"Alternate Question Text","description":"Does the patient have a history of prior invasive malignancy (unless disease free for a minimum of 3 years ), excluding non-melanomatous skin cancer such as carcinoma in situ of the breast, oral cavity or cervix?","url":null,"context":"NRG"},{"name":"NRG_CRF Text5","type":"Alternate Question Text","description":"Has the patient had any prior malignancies in the past 3 years other than squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ or carcinoma in situ of the cervix or oral cavity that has been effectively treated?","url":null,"context":"NRG"},{"name":"CRF Text 34","type":"Alternate Question Text","description":"Does the patient have a histologically proven diagnosis of endometrioid endometrial adenocarcinoma by endometrial curettage or biopsy within 8 weeks prior to registration?","url":null,"context":"CTEP"},{"name":"CRF Text 35","type":"Alternate Question Text","description":"Has the patient had other malignancies?","url":null,"context":"CTEP"},{"name":"CRF Text36","type":"Alternate Question Text","description":"Other malignancy within 5 years of registration","url":null,"context":"Alliance"},{"name":"MA39","type":"Alternate Question Text","description":"Patient has a history of non-breast malignancies except adequately treated non-melanoma skin cancers, in situ cancers treated by local excision or other cancers curatively treated with no evidence of disease for greater than or equal toÂ 5 years.","url":null,"context":"CCTG"},{"name":"CRF Text37","type":"Alternate Question Text","description":"Patient not on active treatment for cancer, does not carry a current diagnosis of any cancer, and/or hasn't been investigated for suspicion of recurrence of past cancer.","url":null,"context":"Alliance"},{"name":"CRF Text 37","type":"Alternate Question Text","description":"Prior invasive malignancy (except non-melanomatous skin cancer or low risk prostate cancer) unless disease free for a minimum of 2 years?","url":null,"context":"NRG"},{"name":"CRF Text 28","type":"Alternate Question Text","description":"Has the patient had antineoplastic therapy (e.g., chemotherapy or targeted therapy) for other invasive cancer within the past 5 years?","url":null,"context":"CTEP"},{"name":"CRF Text 38","type":"Alternate Question Text","description":"Does the patient have curatively treated other solid tumors including lymphomas (without bone marrow involvement) with no evidence of disease for the last 5 or more years?","url":null,"context":"CTEP"},{"name":"CRF Text 29","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (except non-melanomatous skin cancer)?","url":null,"context":"CTEP"},{"name":"CRF Text 40","type":"Alternate Question Text","description":"Has the patient had a prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of the investigational regimen?","url":null,"context":"CTEP"},{"name":"CRF Text 30","type":"Alternate Question Text","description":"Has the patient had a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen?","url":null,"context":"CTEP"},{"name":"CRF Text 41","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (except breast DCIS/LCIS, non-melanomatous skin cancer, adequately treated carcinoma in-situ of the cervix or superficial transitional cell carcinoma of the bladder) and has not been disease free for greater than or equal to 3 years?","url":null,"context":"NRG"},{"name":"CRF Text 50","type":"Alternate Question Text","description":"Does the participant have previous malignancies unless the patient has been disease free for 5 or more years prior to randomization and is deemed by the physician to be at low risk for recurrence?","url":null,"context":"CTEP"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"Has the participant ever had cancer confirmed by a doctor","url":null,"context":"DCP"},{"name":"NRG_CRF_Text8","type":"Alternate Question Text","description":"Does the patient have a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Does the patient have a prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of the investigational regimen?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Has the patient had any other invasive malignancy within 5 years before study entry?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text7","type":"Alternate Question Text","description":"Does the patient have a prior or concurrent malignacy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen?","url":null,"context":"NRG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Patient with prior or concurrent malignancy whose natural history or treatment does NOT have the potential to interfere with the safety or efficacy assessment of the investigational regimen.","url":null,"context":"CCTG"},{"name":"NRG_CRF_Text_51","type":"Alternate Question Text","description":"Does the patient have a prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of the investigational regimen?","url":null,"context":"NRG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Does the patient have a prior or concurrent non-breast malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of the investigational regimen?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_9","type":"Alternate Question Text","description":"Has the patient had any other invasive malignancy within 5 years before Step 1/Study entry?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D90CD8A6-34D7-7108-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-27","modifiedBy":"TYRRELLM","dateModified":"2023-09-28","changeDescription":"Replaced VD Assessments Ind-2 2018320v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"9.28.2023 Added AQT per request CADSR0002895_mmt\r\n7/21/23 removed special character from AQT_mmt","unresolvedIssues":null,"deletedIndicator":"No"}}